AAD 2026: Longevity, GLP-1, and Scalp Care Define the Next Phase of Growth in Professional Beauty

Picture of Dana Kreutzer

Dana Kreutzer

Project Manager, Beauty and Wellbeing

The exhibit floor at the American Academy of Dermatology (AAD) 2026 annual meeting in Denver was a vibrant microcosm of an industry in transition. As the boundaries between professional, luxury, and mass skin care continue to blur, this year’s show highlighted a strategic pivot toward longevity, omnichannel sophistication, and head-to-toe clinical care. 

Drawing on conversations with industry leaders and on-the-ground observations, here are the shifts redefining the professional beauty market: 

The Scalp and Hair Loss “Gold Rush” 

Perhaps the most visible shift this year was the elevation of scalp care and hair loss from a niche adjacency to a core category. We saw engagement across the spectrum, from topical professional brands to aesthetic and pharma companies, all eyeing the scalp as the “new face.”  

KilgourMD debuted with its prevention-plus-treatment approach, positioning its scalp care as a clinical alternative to traditional minoxidil. Legacy pro players such as Obagi entered the fray last year, and the rise of nutraceuticals (including Nutrafol and Xstresse) further reinforces that the “pro-skin” conversation now officially includes internal wellness and hair density. 

From Anti-Aging to Longevity and GLP-1 

The conversation is clearly shifting away from “anti-aging” to longevity and preventative health. Many companies shared that life-stage science is emerging as one of the biggest drivers in the aesthetics space right now.  

There is also a growing focus on understanding the GLP-1 consumer journey in beauty. Several companies are planning clinical studies specifically targeting the users of GLP-1 medications, looking at how their topical skin care products can address the unique skin concerns tied to rapid weight loss. SkinCeuticals has already taken a step here with its A.G.E. Interrupter Ultra Serum launched last year. 

High-Tech Sunscreen and Clinical Flagships

Sunscreen remains the ultimate “gateway” product in the derm office, but the innovation bar has been raised. Excitement is building around the latest sunscreen filter in the United States, Parsol Shield, as brands race to combine superior protection with elegant, “invisible” wearability.

SkinCeuticals generated buzz with the launch of its Future Mineral UV Defense Invisible Sunscreen, while EltaMD used the show to focus on scientific storytelling and efficacy demonstrations, particularly with their new UV Clear innovation, UV Clear Blemish-Prone & Oil Balancing SPF 50. 

Clinique display at in-cosmetics 2026
A featured display at in-cosmetics 2026 highlights continued emphasis on dermatological efficacy and high-SPF sun protection in skin care formulations.
EltaMD display at in-cosmetics 2026

The “Derm-Developed” Mass Evolution 

One of the most notable trends at AAD 2026 was the growing presence of brands, traditionally found in Target or Sephora, seeking professional validation. Prequel, a derm-developed skin care brand that has gained massive traction at Target, officially launched Prequel Professional. The brand is taking a page from the CeraVe/Cetaphil playbook by focusing on a professional sampling program to drive dermatologist recommendations.  

We also witnessed the AAD debut of “luxe-mass” and K-Beauty favorites such as Byoma, Dr. Dennis Gross, Glow Recipe, and Peach Slices, signaling that the “professional” floor is becoming a vital destination for any brand rooted in barrier care and clinical efficacy. 

CeraVe display at in-cosmetics 2026
CeraVe display at in-cosmetics 2026
Byoma display at in-cosmetics 2026
Byoma display at in-cosmetics 2026

New Entrants and Strategic Re-Entry 

Momentum is building across both emerging players and heritage skin care brands rethinking how they show up in the professional channel. Face Reality, an esthetician-founded brand with a strong spa presence, is quickly expanding into medical settings, including dermatology offices and med spas, driven by its authority in acne care. At the same time, its gentle, barrier-supportive daily skin care offerings are proving versatile across a broader range of treatment environments, helping fuel that expansion.  

On the heritage side, NeoStrata is making a major move back into the professional channel with the launch of a dedicated B2B site, already experiencing early traction.  

AAD 2026 proved that the professional channel is no longer a silo. It is an ecosystem where high-science topicals, aesthetics, hair health, and mass-market skin care darlings all compete for the dermatologist’s “seal of approval.”  

For beauty brands, winning in this environment will require connecting clinical credibility with evolving consumer journeys, from longevity-driven routines to GLP-1-related needs and scalp-focused solutions. To explore how these shifts translate into growth opportunities for your brandcontact Kline’s Beauty and Wellbeing team

Smart Data. Trusted Expertise. Better Decisions.